Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating?

Boots has a new owner: Three ways it could affect you

bbc.co.uk · 10.10

Analysis: Trump's shock Russia deal highlights mounting pressure to curb fuel prices

bbc.co.uk · 10.10

Why OpenAI’s revenue numbers really matter

ft.com · 09.10

The hazy OpenAI growth metric driving Wall Street

ft.com · 09.10

Trump taps Russia to boost global diesel supplies ahead of midterms. It may be ‘too little, too late,’ says strategist.

marketwatch.com · 09.10

JD Vance casts doubt on Pentagon’s plan to livestream execution

ft.com · 09.10